Kjell Olmarker

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Sciaticon Ab, Stayble Therapeutics Ab, A+ Science Ab (Publ). Active years: 2003-2019.

USPTO Granted Patents = 13 (Patent Applications = 5)

% Patents Active = 38.5

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 57(Granted Patents)

Location History:

Molndal, SE (2010 - 2011)
Mölndal, SE (2003 - 2019)
Moelndal, SE (2019)

Company Filing History:

Stayble Therapeutics Ab

Pharmasurgics in Sweden Ab

patents

Years Active: 2003-2019

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10322098 - Composition for use in the treatment of intervertebral disc-related pain (2019-06-18),

2. 10265284 - Composition for use in the treatment of intervertebral disc-related pain (2019-04-23),

3. 10080729 - Composition for use in the treatment of intervertebral misalignment (2018-09-25),

4. 8057792 - Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus (2011-11-15),

5. 7994116 - Methods for reduction of adhesion formation using cytokine inhibitors (2011-08-09),

6. 7906481 - Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus (2011-03-15),

7. 7811990 - Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus (2010-10-12),

8. 7723357 - Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus (2010-05-25),

9. 7708995 - Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus (2010-05-04),

10. 7427589 - Use of cytokine inhibitors (2008-09-23),

11. 7115557 - Use of certain drugs for treating nerve root injury (2006-10-03),

12. 6649589 - Use of certain drugs for treating nerve root injury (2003-11-18),

13. 6635250 - Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus (2003-10-21),

Title: Kjell Olmarker: Innovator in Intervertebral Disc Treatment

Introduction

Kjell Olmarker is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of medical treatments, particularly focusing on intervertebral disc-related pain. With a total of 13 patents to his name, Olmarker has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents, Olmarker has developed compositions aimed at treating intervertebral disc-related pain. These compositions are designed to address various types of pain, including low back pain, chronic low back pain, neck pain, chronic neck pain, and coccygodynia. One of his notable inventions involves a composition that includes lactic acid or a pharmaceutically acceptable salt thereof, which is administered into the disc space containing the nucleus pulposus of an intervertebral disc. Another patent focuses on a composition with lactic acid that has a pH below 4, also intended for administration into the disc space.

Career Highlights

Throughout his career, Kjell Olmarker has worked with several companies, including Sciaticon AB and Stayble Therapeutics AB. His work has been instrumental in advancing treatments for intervertebral disc-related conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Olmarker has collaborated with notable individuals in his field, including Bjorn Rydevik and Björn Rydevik. These partnerships have contributed to the development and refinement of his innovative treatments.

Conclusion

Kjell Olmarker is a distinguished inventor whose work in the treatment of intervertebral disc-related pain has made a significant impact in the medical field. His numerous patents and collaborations highlight his dedication to advancing healthcare solutions.